🔗 Permalink

Inventor profile of:

Ole Olsen

City:

Everett, Washington

Country:

United States

Published Applications:

Last publication date:

2026-01-08

Top Assignees for applications by Ole Olsen

The entities that hold a legal rights for patent applications filed by inventor Olsen Ole:

Theraclone Sciences, Inc. 27 Seattle, WA United States
The Scripps Research Institute 14 La Jolla, CA United States
International AIDS Vaccine Initiative 9 New York, NY United States
International AIDS Vaccine Initiative Inc. 5 New York, NY United States
SYSTIMMUNE, INC. 4 Redmond, WA United States
BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD. 3 Chengdu, China
BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD. 2 Sichuan, China
SYSTIMMUNE, INC. 1 Rdmond, WA United States
SPALTUDAQ CORP. 1 Seattle, WA United States

Recent patent applications by Olsen Ole

Ole Olsen from Everett, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-08

US20260008861A9

Chemistry; metallurgy

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#2 | 2025-12-11

US20250376531A9

Chemistry; metallurgy

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#3 | 2025-10-16

US20250320281A1

Chemistry; metallurgy

METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES

#4 | 2024-10-17

US20240343782A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#5 | 2024-08-22

US20240279333A1

Chemistry; metallurgy

MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#6 | 2024-04-25

US20240132578A1

Chemistry; metallurgy

METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES

#7 | 2024-03-14

US20240084026A1

Chemistry; metallurgy

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#8 | 2024-02-29

US20240067741A1

Chemistry; metallurgy

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#9 | 2023-10-12

US20230322920A1

Chemistry; metallurgy

MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#10 | 2023-09-21

US20230295278A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#11 | 2023-01-26

US20230027965A1

Chemistry; metallurgy

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

#12 | 2022-01-06

US20220002425A1

Chemistry; metallurgy

GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHOD OF MAKING AND USING THEREOF

#13 | 2022-01-06

US20220002406A1

Chemistry; metallurgy

Multi-specific antibodies and methods of making and using thereof

#14 | 2021-09-09

US20210277109A1

Chemistry; metallurgy

Anti-ROR1 antibodies and methods of making and using thereof

#15 | 2021-06-24

US20210188989A1

Chemistry; metallurgy

Anti-4-1BB antibodies and methods of making and using thereof

#16 | 2021-02-11

US20210040186A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#17 | 2021-01-28

US20210024630A1

Chemistry; metallurgy

Guidance and Navigation Control proteins and method of making and using thereof

#18 | 2021-01-14

US20210008113A1

Human necessities

METHODS OF MAKING AND USING GUIDANCE AND NAVIGATION CONTROL PROTEINS

#19 | 2020-05-21

US20200157224A1

Chemistry; metallurgy

MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#20 | 2020-05-21

US20200157217A1

Chemistry; metallurgy

Anti-CD3 antibodies and methods of making and using thereof

#21 | 2020-05-21

US20200157213A1

Chemistry; metallurgy

Tri-specific antibodies

#22 | 2020-01-23

US20200024330A1

Chemistry; metallurgy

Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies

#23 | 2019-11-07

US20190338017A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#24 | 2019-06-06

US20190169273A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#25 | 2019-01-31

US20190031742A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#26 | 2018-03-01

US20180057570A1

Chemistry; metallurgy

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

#27 | 2016-09-15

US20160264649A1

Chemistry; metallurgy

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

#28 | 2015-08-06

US20150218257A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#29 | 2015-07-09

US20150191531A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CYTOMEGALOVIRUS INFECTIONS

#30 | 2015-06-04

US20150152166A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CYTOMEGALOVIRUS

#31 | 2015-04-09

US20150098948A1

Chemistry; metallurgy

Compositions And Methods For The Therapy And Diagnosis Of Influenza

#32 | 2015-03-26

US20150086555A1

Chemistry; metallurgy

Anti-Hemagglutinin Antibody Compositions and Methods of Use Thereof

#33 | 2014-12-11

US20140363441A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA

#34 | 2014-07-24

US20140205612A1

Chemistry; metallurgy

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

#35 | 2014-05-15

US20140135480A1

Chemistry; metallurgy

Compositions and Methods for the Therapy and Diagnosis of Influenza

#36 | 2013-06-20

US20130158238A1

Chemistry; metallurgy

Compositions and Methods for the Therapy and Diagnosis of Influenza

#37 | 2012-12-13

US20120315277A1

Human necessities

Compositions and Methods for the Therapy and Diagnosis of Influenza

#38 | 2012-10-18

US20120263734A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of cytomegalovirus infections

#39 | 2012-08-16

US20120207760A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#40 | 2012-07-05

US20120171218A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#41 | 2012-05-17

US20120121603A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#42 | 2012-02-16

US20120039899A1

Chemistry; metallurgy

Anti-hemagglutinin antibody compositions and methods of use thereof

#43 | 2011-12-15

US20110305708A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of cytomegalovirus

#44 | 2011-03-24

US20110070235A1

Physics

Compositions and methods for the therapy and diagnosis of influenza

#45 | 2011-02-24

US20110044994A1

Chemistry; metallurgy

Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity

#46 | 2011-02-10

US20110033476A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA

#47 | 2010-07-15

US20100178295A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

#48 | 2009-09-10

US20090226433A1

Chemistry; metallurgy

Compositions and methods for the therapy and diagnosis of influenza

InventorID:

301631 ⎘